Hot Deal: Avenzo Therapeutics’ $60M Series B
Avenzo Therapeutics just locked a $60M Series B. Target CEO Athena Countouriotis. Pitch modular GMP manufacturing & supply chain visibility to fill your pipeline.
Published on
Do not index
Do not index
🚀 Battle Card: Avenzo Therapeutics
Quick trigger:
👤 Decision Maker in the News
- Athena Countouriotis, CEO 📧 <aCountouriotis@avenzotx.com>
💡 Why It Matters
- This Avenzo Therapeutics sales trigger signals fresh war chest to scale clinical manufacturing and supply chain → Source
🎯 Core Pain Point
- Scaling GMP manufacturing for small molecules and ADCs
- Ensuring supply chain visibility amid clinical trials
💰 What to Pitch
- Primary: Modular Clinical Manufacturing Services → Reduce time-to-batch & cost
- Expansion: End-to-end Supply Chain Visibility Platform → Ensure trial material integrity & regulatory compliance
🗺️ Quick Context
- HQ: San Diego, CA
- Employees: ≈ 120
- Rev: ≈ $0
🤼 Competitive Intel
*Which other vendors you’ll probably face to win Avenzo Therapeutics’ business.*
- Catalent — Clinical Manufacturing Services
- Unique edge: Global GMP facilities & ADC specialization
- Evaluated by VP Ops & Head of CMC for scale
- Thermo Fisher Scientific — Biopharma Supply Chain
- Unique edge: Integrated reagent-to-commercial supply solutions
- Evaluated by Dir Supply Chain for end-to-end coverage
- TraceLink — Supply Chain Visibility
- Unique edge: Digital track & trace for clinical trials
- Evaluated by QA & Compliance leads for serialization
✅ Do-Now Checklist
Connect with all decision makers on LinkedIn (links above)
Tailor outreach referencing the Avenzo Therapeutics sales trigger
Generate email + DM with the Copy-My-Prompt block (Step 7) and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get intel like this daily—no fluff, all pipeline. Never miss an Avenzo Therapeutics sales trigger.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑<your company>❑
OFFER_BRIEF = ❑<1-line value>❑
PROOF_METRIC = ❑<metric>❑
CTA_STYLE = ❑quick_call | case_study❑
TONE = ❑friendly | punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Athena
COMPANY = Avenzo Therapeutics
DEPT = Supply Chain
SIZE = 10
BOTTLENECK = scaling GMP manufacturing
EVENT = $60M Series B financing
DETAIL = closing of a $60M Series B financing
PAIN = Ensuring supply chain visibility amid clinical trials
SRC = https://vcnewsdaily.com/avenzo-therapeutics/venture-capital-funding/bgczzsxwtm
SIM_CO = ≈ TBD
WIN_METRIC = 25% faster time to batch
NEXT_SIZE = 25
EMP_EST = ≈120
REV_EST = ≈$0
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: 10-person Supply Chain
Athena—noticed your Supply Chain team is ≈ 10.
That’s when scaling GMP manufacturing slows growth.
We helped ≈ TBD fix this with ❑<1-line value>❑.
Result: 25% faster time to batch.
<<CTA_STYLE=="quick_call" ? "Quick call?" : "Want the 2-min recap?">>
PS—next bottleneck hits ≈ 25.
DM ≤45 words, TONE:
Saw your post about closing of a $60M Series B financing — Ensuring supply chain visibility amid clinical trials.
❑<1-line value>. ❑<metric>.
<<CTA_STYLE=="quick_call" ? "Quick chat?" : "Send case study?">>